US Stock MarketDetailed Quotes

DERM Journey Medical

Watchlist
  • 3.680
  • -0.210-5.40%
Close Mar 28 16:00 ET
  • 3.650
  • -0.030-0.82%
Post 16:48 ET
71.11MMarket Cap-17523P/E (TTM)

Journey Medical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Total revenue
114.31%34.54M
-6.12%17.17M
-47.57%12.21M
16.69%73.67M
-8.85%15.97M
-17.82%16.12M
19.64%18.29M
117.33%23.3M
41.78%63.13M
27.65%17.52M
Operating revenue
-4.76%15.28M
-6.99%16.96M
-41.50%12.17M
12.52%71M
-8.92%15.92M
-18.19%16.04M
19.28%18.24M
94.01%20.8M
41.22%63.1M
27.43%17.48M
Cost of revenue
-10.97%6.43M
1.76%7.77M
-21.38%6.45M
-4.08%30.78M
-18.97%7.72M
-35.34%7.22M
1.99%7.63M
109.90%8.2M
119.84%32.08M
122.49%9.53M
Gross profit
216.02%28.11M
-11.76%9.41M
-61.81%5.76M
38.14%42.89M
3.20%8.25M
5.35%8.9M
36.57%10.66M
121.60%15.09M
3.72%31.05M
-15.36%7.99M
Operating expense
-40.91%10.87M
-21.83%13.92M
-4.10%15.33M
24.86%70.41M
7.00%18.24M
59.21%18.39M
-17.47%17.8M
156.68%15.98M
155.32%56.39M
193.14%17.05M
Selling and administrative expenses
-44.55%8.64M
-20.08%12.14M
-9.67%13.29M
49.29%59.47M
-7.11%13.99M
44.82%15.58M
94.88%15.19M
136.35%14.72M
80.35%39.83M
158.89%15.06M
Research and development costs
-20.73%2.23M
-32.00%1.77M
60.58%2.03M
-33.91%10.94M
113.65%4.26M
254.16%2.81M
-81.06%2.61M
--1.27M
--16.56M
--1.99M
Operating profit
281.68%17.25M
36.85%-4.51M
-976.69%-9.56M
-8.59%-27.52M
-10.36%-10M
-205.60%-9.49M
48.11%-7.14M
-251.79%-888K
-422.77%-25.34M
-349.78%-9.06M
Net non-operating interest income expense
53.24%-260K
-50.44%-677K
-36.79%-528K
72.14%-1.96M
86.16%-567K
59.50%-556K
66.47%-450K
-74.66%-386K
-907.45%-7.03M
-1,888.35%-4.1M
Non-operating interest income
166.67%8K
1,875.00%79K
3,966.67%122K
2,900.00%60K
2,400.00%50K
--3K
--4K
--3K
--2K
--2K
Non-operating interest expense
-52.06%268K
66.52%756K
67.10%650K
-71.30%2.02M
-84.94%617K
-59.29%559K
-66.04%454K
76.02%389K
907.74%7.03M
1,889.32%4.1M
Other net income (expense)
-359.09%-101K
-3.18M
-47K
99.11%-89K
74.52%-67K
99.77%-22K
-9.99M
-263K
Gain on sale of security
-359.09%-101K
---33K
---47K
80.09%-89K
74.52%-67K
-1,000.00%-22K
----
----
---447K
---263K
Special income (charges)
--0
---3.14M
----
--0
--0
--0
--0
----
---9.54M
--0
-Less:Impairment of capital assets
--0
--3.14M
----
----
----
--0
--0
----
----
----
-Less:Other special charges
----
----
----
----
----
----
----
----
--9.54M
--0
Income before tax
267.67%16.88M
-10.16%-8.36M
-695.60%-10.14M
30.21%-29.57M
20.77%-10.63M
28.18%-10.07M
50.34%-7.59M
-450.00%-1.27M
-692.20%-42.36M
-492.28%-13.42M
Income tax
850.00%95K
0
0
-96.14%63K
-99.84%13K
100.30%10K
98.13%-64K
8.33%104K
-12.62%1.63M
807.95%8.34M
Net income
266.56%16.79M
-11.09%-8.36M
-635.56%-10.14M
32.65%-29.63M
51.07%-10.64M
5.32%-10.08M
36.55%-7.53M
-614.18%-1.38M
-932.75%-43.99M
-969.34%-21.75M
Net income continuous Operations
266.56%16.79M
-11.09%-8.36M
-635.56%-10.14M
32.65%-29.63M
51.07%-10.64M
5.32%-10.08M
36.55%-7.53M
-614.18%-1.38M
-932.75%-43.99M
-969.34%-21.75M
Minority interest income
Net income attributable to the parent company
266.56%16.79M
-11.09%-8.36M
-635.56%-10.14M
32.65%-29.63M
51.07%-10.64M
5.32%-10.08M
36.55%-7.53M
-614.18%-1.38M
-932.75%-43.99M
-969.34%-21.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
266.56%16.79M
-11.09%-8.36M
-635.56%-10.14M
32.65%-29.63M
51.07%-10.64M
5.32%-10.08M
36.55%-7.53M
-614.18%-1.38M
-932.75%-43.99M
-969.34%-21.75M
Basic earnings per share
259.65%0.91
-6.98%-0.46
-612.50%-0.57
60.88%-1.69
63.41%-0.6
50.86%-0.57
66.80%-0.43
-373.48%-0.08
-849.06%-4.32
-700.50%-1.64
Diluted earnings per share
240.35%0.8
-6.98%-0.46
-612.50%-0.57
60.88%-1.69
63.41%-0.6
50.86%-0.57
66.80%-0.43
-373.48%-0.08
-849.06%-4.32
-700.50%-1.64
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Total revenue 114.31%34.54M-6.12%17.17M-47.57%12.21M16.69%73.67M-8.85%15.97M-17.82%16.12M19.64%18.29M117.33%23.3M41.78%63.13M27.65%17.52M
Operating revenue -4.76%15.28M-6.99%16.96M-41.50%12.17M12.52%71M-8.92%15.92M-18.19%16.04M19.28%18.24M94.01%20.8M41.22%63.1M27.43%17.48M
Cost of revenue -10.97%6.43M1.76%7.77M-21.38%6.45M-4.08%30.78M-18.97%7.72M-35.34%7.22M1.99%7.63M109.90%8.2M119.84%32.08M122.49%9.53M
Gross profit 216.02%28.11M-11.76%9.41M-61.81%5.76M38.14%42.89M3.20%8.25M5.35%8.9M36.57%10.66M121.60%15.09M3.72%31.05M-15.36%7.99M
Operating expense -40.91%10.87M-21.83%13.92M-4.10%15.33M24.86%70.41M7.00%18.24M59.21%18.39M-17.47%17.8M156.68%15.98M155.32%56.39M193.14%17.05M
Selling and administrative expenses -44.55%8.64M-20.08%12.14M-9.67%13.29M49.29%59.47M-7.11%13.99M44.82%15.58M94.88%15.19M136.35%14.72M80.35%39.83M158.89%15.06M
Research and development costs -20.73%2.23M-32.00%1.77M60.58%2.03M-33.91%10.94M113.65%4.26M254.16%2.81M-81.06%2.61M--1.27M--16.56M--1.99M
Operating profit 281.68%17.25M36.85%-4.51M-976.69%-9.56M-8.59%-27.52M-10.36%-10M-205.60%-9.49M48.11%-7.14M-251.79%-888K-422.77%-25.34M-349.78%-9.06M
Net non-operating interest income expense 53.24%-260K-50.44%-677K-36.79%-528K72.14%-1.96M86.16%-567K59.50%-556K66.47%-450K-74.66%-386K-907.45%-7.03M-1,888.35%-4.1M
Non-operating interest income 166.67%8K1,875.00%79K3,966.67%122K2,900.00%60K2,400.00%50K--3K--4K--3K--2K--2K
Non-operating interest expense -52.06%268K66.52%756K67.10%650K-71.30%2.02M-84.94%617K-59.29%559K-66.04%454K76.02%389K907.74%7.03M1,889.32%4.1M
Other net income (expense) -359.09%-101K-3.18M-47K99.11%-89K74.52%-67K99.77%-22K-9.99M-263K
Gain on sale of security -359.09%-101K---33K---47K80.09%-89K74.52%-67K-1,000.00%-22K-----------447K---263K
Special income (charges) --0---3.14M------0--0--0--0-------9.54M--0
-Less:Impairment of capital assets --0--3.14M--------------0--0------------
-Less:Other special charges ----------------------------------9.54M--0
Income before tax 267.67%16.88M-10.16%-8.36M-695.60%-10.14M30.21%-29.57M20.77%-10.63M28.18%-10.07M50.34%-7.59M-450.00%-1.27M-692.20%-42.36M-492.28%-13.42M
Income tax 850.00%95K00-96.14%63K-99.84%13K100.30%10K98.13%-64K8.33%104K-12.62%1.63M807.95%8.34M
Net income 266.56%16.79M-11.09%-8.36M-635.56%-10.14M32.65%-29.63M51.07%-10.64M5.32%-10.08M36.55%-7.53M-614.18%-1.38M-932.75%-43.99M-969.34%-21.75M
Net income continuous Operations 266.56%16.79M-11.09%-8.36M-635.56%-10.14M32.65%-29.63M51.07%-10.64M5.32%-10.08M36.55%-7.53M-614.18%-1.38M-932.75%-43.99M-969.34%-21.75M
Minority interest income
Net income attributable to the parent company 266.56%16.79M-11.09%-8.36M-635.56%-10.14M32.65%-29.63M51.07%-10.64M5.32%-10.08M36.55%-7.53M-614.18%-1.38M-932.75%-43.99M-969.34%-21.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 266.56%16.79M-11.09%-8.36M-635.56%-10.14M32.65%-29.63M51.07%-10.64M5.32%-10.08M36.55%-7.53M-614.18%-1.38M-932.75%-43.99M-969.34%-21.75M
Basic earnings per share 259.65%0.91-6.98%-0.46-612.50%-0.5760.88%-1.6963.41%-0.650.86%-0.5766.80%-0.43-373.48%-0.08-849.06%-4.32-700.50%-1.64
Diluted earnings per share 240.35%0.8-6.98%-0.46-612.50%-0.5760.88%-1.6963.41%-0.650.86%-0.5766.80%-0.43-373.48%-0.08-849.06%-4.32-700.50%-1.64
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg